NPS injecting harms and harm reduction. Psychoactive Substances Health Workshop Friday 4 th March 2016 Emma Hamilton A national resource of expertise on.

Slides:

Advertisements

Similar presentations

Injecting drug use and infections. Vivian Hope IDU Team, HIV & STI Department, Health Protection Services – Colindale Dr Vivian Hope, Dr Fortune Ncube.

Advertisements

Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.

Needle and syringe programmes Implementing NICE guidance 2009 NICE public health guidance 18.

2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.

Substance misuse sector Or Sexual health sector? Is this a drug problem Or A sex problem?

Turning a Negative into a Positive Janet Keauffling Nurse for Homeless & Vulnerable Adults.

Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.

Recreational Insanity With Katy MacLeod- Training and Outreach Coordinator Crew Page 1.

What is a drug death? Dr Marjorie Black Forensic Medicine and Science University of Glasgow.

Harm Reduction and safer injecting Aim To understand the complexity of substance use behaviour Gain insight into why it is hard for some people to stop.

The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.

Novel Psychoactive Substances

Cocaine Services IN AN IDEAL WORLD – HOW SHOULD THEY WORK?

Working with SEPs: How do we expand Hepatitis Services ? Narelle Ellendon, RN HCV Director Harm Reduction Coalition, NYC

Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.

HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.

Understanding the IDU community and their vulnerabilities 1.

Annual report 2010: the state of the drugs problem in Europe.

Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.

All Change! Infections, injecting drug use and harm reduction. Vivian Hope IDU Team, HIV & STI Department, Health Protection Services – Colindale Dr Vivian.

Barnardo’s Registered Charity Nos and SC PINS National Seminar: Mental and emotional health & wellbeing in schools – what role for the voluntary.

Drug Use and Hepatitis C Are we mindful of the gaps? Dave Liddell, SDF.

Reaching out to drug users and communities “ ” WDP Preventing HIV Yasmin Batliwala.

ISD data sources Making sense of the statistics Anthea Springbett Principal Statistician Substance Misuse Team, ISD.

Module 7: Physical Health Needs Assessment. Objectives To understand the concept of harm minimisation. To be aware of the physical risks involved in drug.

Harm Reduction International

Impact of the 2003 ‘paraphernalia law’ change on UK needle exchange agencies Jenny Scott Dept Pharmacy & Pharmacology University of Bath.

Senior Drug Users: Scotland April Shaw & Austin Smith November 2009.

Epidemiology of addictive disorders: a brief review MRCPsych addiction psychiatry seminar series Dr Stuart McLaren 2 nd March 2012.

Global Fund in Estonia Kaja Põlluste, MD, MPH Department of Public Health & Department of Internal Diseases University of Tartu Estonia.

Austin Smith Policy & Practice Officer. Greater Glasgow & Clyde Legal Highs Monitoring Group Representatives from – Police Health Addiction Services Scottish.

Harm Reduction Team Maureen Woods Team Leader. Service Delivery Aims Develop harm reduction initiatives in partnership with other agencies to reduce the.

Substance Misuse Treatment Framework – Needle Exchange Implications for planning and practice Carry Burton North Wales Needle Syringe Programme & Harm.

Problematic and injecting drug use – findings from the Harm Reduction Database (HRD) Presenter: Josie Smith, Health Protection, PHW.

1 NTA More treatment, better treatment, fairer treatment National injecting conference Annette Dale-Perera Director of Quality.

Provision of Services at Bradbury House, a Drop in Centre for the Homeless and Vulnerably Housed.

News From Needle Exchanges What the staff say John Campbell March 2009 ScottishdrugsForum.

Evidence-based practice guidelines: Chronic harms of substance use.

1 John Campbell.  Poor UK survey Data  Small area or location studies  Glasgow accurate NEO data.

Young Person’s substance misuse service in Hampshire Julie Poling – Team Leader.

Trauma and Recovery amongst people who have injected drugs within the past 5 years SDF, Professor Richard Hammersley and Dr Phil Dalgarno A national resource.

NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.

Annual report 2012: the state of the drugs problem in Europe Name, date.

The challenge of responding to NPS injecting: A change in service provision Vicki Craik NPS and Training Coordinator.

Developing role of community pharmacy in responding to the needs of people with drug problems David Thomson Lead Pharmacist Community Pharmacy Development.

SDF Conference 2014 Data Collection: Issues and Responses Marie Wilson Addictions Education & Prevention Specialist, NHS A&A Jo McManus Health Improvement.

Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,

New Psychoactive Substances: an overview of the evidence Isla Wallace, Social Researcher Drugs Research Team

NPS Intravenous Use in the UK: Current Situation and Experiences Catherine Crawford, UK Focal Point.

Drug-related deaths Phil Conley Health Improvement Programme Manager September 2015.

Addiction Workers Training Project Amy Kirkpatrick, AWTP Development and Co-ordinator, Audrey Smart A national resource of expertise on drug issues.

§ NPS research Katy MacLeod National Training and Development Officer A national resource of expertise on drug issues.

Tackling Stigma with Naloxone Peer Education Jason Wallace National Naloxone Training and Support Officer

A DAY IN THE LIFE OF BOOTS QUEEN STREET STATION Lynda Allan Store Manager.

Presentation Title Speaker’s name Presentation title Speaker’s name Housing First: Retention and Recovery Patrick McKay.

Substance Misuse in LGBT populations

6% of adults had used one or more illicit drugs in last 12 months.

Enhanced Pharmacy Provision in Edinburgh:

Reitox National Focal Point National Bureau for Drug Prevention

Community Pharmacy Injecting Equipment Provision -new service 2017-

Drug-Related Deaths in Suffolk Alison Amstutz Senior Health Improvement Commissioner (Sexual Health and Drugs and Alcohol) Public Health, Suffolk County.

MENTAL HEALTH and SUBSTANCE MISUSE

NPS current health-related practices and challenges in responding to use and harms in Europe Findings from a multi-method study Alessandro Pirona Lisbon.

Is Alcohol a Problem? -Setting the Scene

Drug use among MSM (overview with focus on chemsex)

Where does the water come from?

Dave Liddell - CEO, Scottish Drugs Forum DRNS Conference 2018

German Drug and Addiction Policy

Test of Change Workshop

Presentation transcript:

NPS injecting harms and harm reduction. Psychoactive Substances Health Workshop Friday 4 th March 2016 Emma Hamilton A national resource of expertise on drug issues

2 Injecting NPS – what is being used? Who injects NPS? Patterns associated with stimulant injecting What are the harms associated with injecting NPS? NHS Lothian case study Wider harms of NPS use Concerns of frontline staff Contents:

3 Stimulants: Amphetamine Cocaine Methamphetamine Mephedrone Mexedrone Methiopropamine (MPA) Ethylphenidate Dissociatives: Ketamine Methoxetamine

Who injects NPS? Homeless Mental health Opiate injectors MSM 4

5

Injecting patterns Frequent injecting Bingeing High risk injecting – sharing, reusing, not filtering Higher levels of risk behaviours associated with injecting NPS can increase their harm ie.. High risk/ rough sex, missing medications, bacterial infection 6

Microcrystalline Cellulose 7

8

9 Problem with NPS injecting since early Bacterial infection outbreak Sept 2014 – Oct 2015 TCDO – Ethylphenidate (April 2015) TCDO – Methiopropamine (Nov 2015) Now considered unlawful in Edinburgh for shops to sell NPS (Oct/ Nov 2015) Case study: NHS Lothian

10

11

12

13

14

15

Harm reduction information for service users: 16 No need to add acidifyer to NPS prior to injection No need to heat Always filter substances New injecting equipment (needle, syringe, spoon, filter) Use water for injection or cooled boiled water Rotate sites Do not share or let others inject you

17

18 Poor mental health (low mood/ psychosis/ suicide) Physical dependency and withdrawal Social problems Financial problems Brain development in young people Wider harms of NPS use

Seeking out/ returning to illicit drugs Targeted Naloxone campaign Safer injecting advice! Already happened in Edinburgh... Burst How can we get in touch with this population? Do we have plans in place to deal with withdrawal? Should we prepare our services for more stimulant injecting? Are we asking our IPED clients about NPS? 19 Future considerations CHEMSEX IPEDs Stimulant Injecting WithdrawalStockpiling

20 Mark Adley - The Drugs Wheel EMCDDA – New Psychoactive Substances in Europe 2015 Public Health England – Shooting Up Report 2015 Katy MacLeod, Michelle O’Loughlin - Scottish Drugs Forum Con Lafferty NHS Lothian SDF, NHS GG&C, Frontier medical “Safer Injecting Basics for NPS” Available online: and-media/sdf-news/injecting-nps-advice/ References and Thanks

Main Office Scottish Drugs Forum 91 Mitchell Street Glasgow G1 3LN t: f: e: Edinburgh 139 Morrison Street Edinburgh EH3 8AJ t: f: e: Scottish Drugs Forum (SDF) is a company limited by guarantee, registration no with charitable status and is also a registered Scottish charity registered SC Registered Office: 91 Mitchell Street, Glasgow, G1 3LN Find drug services in your area: Hepatitis Scotland Take Home Naloxone